129 GRI content index Statement of use Sai Life Sciences has reported the information cited in this GRI content index for the period 1st April 2023 to 31st March 2024 with reference to the GRI Standards. GRI 1 used GRI 1: Foundation 2021 Disclosures Description Page Nos. GRI 2: General Disclosures 2021 2-1 Organizational details 8, 9, 11, 13, 14 2-2 Entities included in the organization’s sustainability reporting 3 2-3 Reporting period, frequency and contact point 3, 134 2-5 External assurance 3 2-6 Activities, value chain and other business relationships 8, 11, 13, 14, 32 2-7 Employees 9, 80 2-8 Workers who are not employees 80, 88, 92 2-9 Governance structure and composition 23, 24 (Annual report) 2-10 Nomination and selection of the highest governance body 18, 19, 22, 23 (Annual report) 2-11 Chair of the highest governance body 18, 19, 22, 23 (Annual report) 2-12 Role of the highest governance body in overseeing the management of impacts 18, 19, 22, 23 (Annual report) 2-13 Delegation of responsibility for managing impacts 18, 19, 22, 23 (Annual report) 2-14 Role of the highest governance body in sustainability reporting 26, 65 2-15 Conflicts of interest 27, 88 2-16 Communication of critical concerns 27 2-17 Collective knowledge of the highest governance body 25, 26 2-18 Evaluation of the performance of the highest governance body 25 (Annual report) 2-19 Remuneration policies 220 23 (Annual report) 2-20 Process to determine remuneration 23 (Annual report) 2-21 Annual total compensation ratio 10, 11 (Annual report) 2-22 Statement on sustainable development strategy 16-21 2-23 Policy commitments 22 2-24 Embedding policy commitments 6, 27, 28, 48, 86-88, 98-100 Some of the GRI disclosures are referenced in our annual report as indicated. Our annual report of FY 2024 is found in the weblink below: https://www.sailife.com/wp-content/uploads/2024/10/25th-Annual-Report-SLS-FY2023-24.pdf
RkJQdWJsaXNoZXIy MTIwMDc4NQ==